azoxymethane has been researched along with humulene in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borrelli, F; Cascio, MG; Izzo, AA; Pagano, E; Pertwee, RG; Romano, B | 1 |
| Borrelli, F; Buono, L; Coppola, D; De Petrocellis, L; Izzo, AA; Maiello, F; Orlando, P; Pagano, E; Panzera, S; Romano, B | 1 |
2 other study(ies) available for azoxymethane and humulene
| Article | Year |
|---|---|
Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol.
Topics: Animals; Azoxymethane; Cannabidiol; Cannabinoid Receptor Antagonists; Cannabis; Carcinogenesis; Carcinoma; Cell Proliferation; Cell Survival; CHO Cells; Colonic Neoplasms; Cricetinae; Cricetulus; Epithelial Cells; HCT116 Cells; Humans; Male; Mice, Inbred ICR; Phytotherapy; Plant Extracts; Random Allocation; Receptors, Cannabinoid; Xenograft Model Antitumor Assays | 2014 |
Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid.
Topics: Animals; Apoptosis; Azoxymethane; Blotting, Western; Cannabinoids; Cannabis; Carcinogens; Cell Proliferation; Cells, Cultured; Colon; Colonic Neoplasms; Flow Cytometry; Humans; Immunoenzyme Techniques; Male; Mice; Mice, Inbred ICR; Mice, Nude; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; TRPM Cation Channels; Xenograft Model Antitumor Assays | 2014 |